Table of Contents

company-logo

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

Cyclo Therapeutics Dividend Announcement

• Cyclo Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cyclo Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cyclo Therapeutics Dividend History

Cyclo Therapeutics Dividend Yield

Cyclo Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cyclo Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Cyclo Therapeutics Financial Ratios

P/E ratio-0.98
PEG ratio0.03
P/B ratio-3.97
ROE10261.33%
Payout ratio0.00%
Current ratio0.45
Quick ratio0.43
Cash Ratio0.11

Cyclo Therapeutics Dividend FAQ

Does Cyclo Therapeutics stock pay dividends?
Cyclo Therapeutics does not currently pay dividends to its shareholders.
Has Cyclo Therapeutics ever paid a dividend?
No, Cyclo Therapeutics has no a history of paying dividends to its shareholders. Cyclo Therapeutics is not known for its dividend payments.
Why doesn't Cyclo Therapeutics pay dividends?
There are several potential reasons why Cyclo Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cyclo Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cyclo Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cyclo Therapeutics a dividend aristocrat?
Cyclo Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cyclo Therapeutics a dividend king?
Cyclo Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cyclo Therapeutics a dividend stock?
No, Cyclo Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cyclo Therapeutics stocks?
To buy Cyclo Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cyclo Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.